266 related articles for article (PubMed ID: 24140884)
1. Skin sensitisation--moving forward with non-animal testing strategies for regulatory purposes in the EU.
Basketter D; Alépée N; Casati S; Crozier J; Eigler D; Griem P; Hubesch B; de Knecht J; Landsiedel R; Louekari K; Manou I; Maxwell G; Mehling A; Netzeva T; Petry T; Rossi LH
Regul Toxicol Pharmacol; 2013 Dec; 67(3):531-5. PubMed ID: 24140884
[TBL] [Abstract][Full Text] [Related]
2. Alternatives for skin sensitisation: Hazard identification and potency categorisation: Report from an EPAA/CEFIC LRI/Cosmetics Europe cross sector workshop, ECHA Helsinki, April 23rd and 24th 2015.
Basketter D; Ashikaga T; Casati S; Hubesch B; Jaworska J; de Knecht J; Landsiedel R; Manou I; Mehling A; Petersohn D; Rorije E; Rossi LH; Steiling W; Teissier S; Worth A
Regul Toxicol Pharmacol; 2015 Nov; 73(2):660-6. PubMed ID: 26456663
[TBL] [Abstract][Full Text] [Related]
3. A European perspective on alternatives to animal testing for environmental hazard identification and risk assessment.
Scholz S; Sela E; Blaha L; Braunbeck T; Galay-Burgos M; García-Franco M; Guinea J; Klüver N; Schirmer K; Tanneberger K; Tobor-Kapłon M; Witters H; Belanger S; Benfenati E; Creton S; Cronin MT; Eggen RI; Embry M; Ekman D; Gourmelon A; Halder M; Hardy B; Hartung T; Hubesch B; Jungmann D; Lampi MA; Lee L; Léonard M; Küster E; Lillicrap A; Luckenbach T; Murk AJ; Navas JM; Peijnenburg W; Repetto G; Salinas E; Schüürmann G; Spielmann H; Tollefsen KE; Walter-Rohde S; Whale G; Wheeler JR; Winter MJ
Regul Toxicol Pharmacol; 2013 Dec; 67(3):506-30. PubMed ID: 24161465
[TBL] [Abstract][Full Text] [Related]
4. Building confidence in skin sensitisation potency assessment using new approach methodologies: report of the 3rd EPAA Partners Forum, Brussels, 28th October 2019.
Basketter D; Beken S; Bender H; Bridges J; Casati S; Corvaro M; Cuvellier S; Hubesch B; Irizar A; Jacobs MN; Kern P; Lamplmair F; Manou I; Müller BP; Roggeband R; Rossi LH
Regul Toxicol Pharmacol; 2020 Nov; 117():104767. PubMed ID: 32866543
[TBL] [Abstract][Full Text] [Related]
5. Non-animal assessment of skin sensitization hazard: Is an integrated testing strategy needed, and if so what should be integrated?
Roberts DW; Patlewicz G
J Appl Toxicol; 2018 Jan; 38(1):41-50. PubMed ID: 28543848
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the performance of integrated approaches for hazard identification of skin sensitizing chemicals.
van der Veen JW; Rorije E; Emter R; Natsch A; van Loveren H; Ezendam J
Regul Toxicol Pharmacol; 2014 Aug; 69(3):371-9. PubMed ID: 24813372
[TBL] [Abstract][Full Text] [Related]
7. Applying non-animal strategies for assessing skin sensitisation report from an EPAA/cefic-LRI/IFRA Europe cross sector workshop, ECHA helsinki, February 7th and 8th 2019.
Basketter D; Azam P; Casati S; Corvaro M; Ezendam J; Griem P; Hubesch B; Irizar A; Kern P; Manou I; Mehling A; Rossi LH
Regul Toxicol Pharmacol; 2019 Dec; 109():104477. PubMed ID: 31586681
[TBL] [Abstract][Full Text] [Related]
8. Report of the EPAA-ECVAM workshop on the validation of Integrated Testing Strategies (ITS).
Kinsner-Ovaskainen A; Maxwell G; Kreysa J; Barroso J; Adriaens E; Alépée N; Berg N; Bremer S; Coecke S; Comenges JZ; Corvi R; Casati S; Dal Negro G; Marrec-Fairley M; Griesinger C; Halder M; Heisler E; Hirmann D; Kleensang A; Kopp-Schneider A; Lapenna S; Munn S; Prieto P; Schechtman L; Schultz T; Vidal JM; Worth A; Zuang V
Altern Lab Anim; 2012 Jul; 40(3):175-81. PubMed ID: 22943518
[TBL] [Abstract][Full Text] [Related]
9. Prediction of skin sensitizers using alternative methods to animal experimentation.
Johansson H; Lindstedt M
Basic Clin Pharmacol Toxicol; 2014 Jul; 115(1):110-7. PubMed ID: 24548737
[TBL] [Abstract][Full Text] [Related]
10. Assuring consumer safety without animal testing: a feasibility case study for skin sensitisation.
Maxwell G; Aleksic M; Aptula A; Carmichael P; Fentem J; Gilmour N; Mackay C; Pease C; Pendlington R; Reynolds F; Scott D; Warner G; Westmoreland C
Altern Lab Anim; 2008 Nov; 36(5):557-68. PubMed ID: 19025323
[TBL] [Abstract][Full Text] [Related]
11. Prediction of skin sensitization potency using machine learning approaches.
Zang Q; Paris M; Lehmann DM; Bell S; Kleinstreuer N; Allen D; Matheson J; Jacobs A; Casey W; Strickland J
J Appl Toxicol; 2017 Jul; 37(7):792-805. PubMed ID: 28074598
[TBL] [Abstract][Full Text] [Related]
12. Application of a systems biology approach to skin allergy risk assessment.
Maxwell G; Mackay C
Altern Lab Anim; 2008 Nov; 36(5):521-56. PubMed ID: 19025322
[TBL] [Abstract][Full Text] [Related]
13. An integrated decision-tree testing strategy for skin sensitisation with respect to the requirements of the EU REACH legislation.
Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
Altern Lab Anim; 2008 Oct; 36 Suppl 1():75-89. PubMed ID: 19025333
[TBL] [Abstract][Full Text] [Related]
14. Regulatory assessment of in vitro skin corrosion and irritation data within the European framework: Workshop recommendations.
Eskes C; Detappe V; Koëter H; Kreysa J; Liebsch M; Zuang V; Amcoff P; Barroso J; Cotovio J; Guest R; Hermann M; Hoffmann S; Masson P; Alépée N; Arce LA; Brüschweiler B; Catone T; Cihak R; Clouzeau J; D'Abrosca F; Delveaux C; Derouette JP; Engelking O; Facchini D; Fröhlicher M; Hofmann M; Hopf N; Molinari J; Oberli A; Ott M; Peter R; Sá-Rocha VM; Schenk D; Tomicic C; Vanparys P; Verdon B; Wallenhorst T; Winkler GC; Depallens O
Regul Toxicol Pharmacol; 2012 Mar; 62(2):393-403. PubMed ID: 22085589
[TBL] [Abstract][Full Text] [Related]
15. Overcoming barriers to validation of non-animal partial replacement methods/Integrated Testing Strategies: the report of an EPAA-ECVAM workshop.
Kinsner-Ovaskainen A; Akkan Z; Casati S; Coecke S; Corvi R; Dal Negro G; De Bruijn J; De Silva O; Gribaldo L; Griesinger C; Jaworska J; Kreysa J; Maxwell G; McNamee P; Price A; Prieto P; Schubert R; Tosti L; Worth A; Zuang V
Altern Lab Anim; 2009 Sep; 37(4):437-44. PubMed ID: 19807215
[TBL] [Abstract][Full Text] [Related]
16. Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation.
Höfer T; Gerner I; Gundert-Remy U; Liebsch M; Schulte A; Spielmann H; Vogel R; Wettig K
Arch Toxicol; 2004 Oct; 78(10):549-64. PubMed ID: 15170526
[TBL] [Abstract][Full Text] [Related]
17. A critical appraisal of the process of regulatory implementation of novel in vivo and in vitro methods for chemical hazard and risk assessment.
Piersma AH; Ezendam J; Luijten M; Muller JJ; Rorije E; van der Ven LT; van Benthem J
Crit Rev Toxicol; 2014 Nov; 44(10):876-94. PubMed ID: 25058877
[TBL] [Abstract][Full Text] [Related]
18. Report from the EPAA workshop: in vitro ADME in safety testing used by EPAA industry sectors.
Schroeder K; Bremm KD; Alépée N; Bessems JG; Blaauboer B; Boehn SN; Burek C; Coecke S; Gombau L; Hewitt NJ; Heylings J; Huwyler J; Jaeger M; Jagelavicius M; Jarrett N; Ketelslegers H; Kocina I; Koester J; Kreysa J; Note R; Poth A; Radtke M; Rogiers V; Scheel J; Schulz T; Steinkellner H; Toeroek M; Whelan M; Winkler P; Diembeck W
Toxicol In Vitro; 2011 Apr; 25(3):589-604. PubMed ID: 21167275
[TBL] [Abstract][Full Text] [Related]
19. A future approach to measuring relative skin sensitising potency: a proposal.
Jowsey IR; Basketter DA; Westmoreland C; Kimber I
J Appl Toxicol; 2006; 26(4):341-50. PubMed ID: 16773645
[TBL] [Abstract][Full Text] [Related]
20. Skin Sensitization: Challenging the Conventional Thinking-A Case Against 2 Out of 3 as Integrated Testing Strategy.
Johansson H; Gradin R
Toxicol Sci; 2017 Sep; 159(1):3-5. PubMed ID: 28633468
[No Abstract] [Full Text] [Related]
[Next] [New Search]
